Q73-20452-27546
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 440 / OH
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-27
Registered in v-safe
-
2021-08-27
Dose 1 — Pfizer-BioNTech
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-09-12
-
2021-09-17
Dose 2 — Pfizer-BioNTech
- 2021-09-17
- 2021-09-18
-
2021-09-20
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis, Paranasal sinus hyposecretion — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: Nosebleed yesterday , dry sinusesMedDRA releases: 2024-11 · check-in free text available
- 2021-09-22
- 2021-09-24
- 2021-10-01
- 2021-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-17 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Nosebleed yesterday , dry sinuses
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Epistaxis | · | · | ✓ |
| SRO | Paranasal sinus hyposecretion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release